Home / Specialties... / Doctors
Zeyu Wu/Chief surgeon MD, Doctoral Supervisor

SPECIALITIES

Thyroid, Parathyroid, Hernia


CLINICAL INTERESTS

He has solid theoretical foundation and rich clinical experience in the standardized treatment for thyroid cancer and parathyroid diseases.


Experience

Visiting Professor and Faculty of Southwestern Medical Center, University of Texas, USA.

Visiting scholar of the German Lipa Hospital.


EDUCATION

MD, Chief surgeon, Doctoral Supervisor


AWARDS AND HONORS

He won the first Guangdong Provincial Outstanding Young Talents in Medicine.

He published more than 80 papers in core journals at home and abroad, including more than 20 SCI papers.

He edited 2 monographs and participated in the editing of 4 monographs.As main member,

he participated in the compilation of many domestic guidelines and expert consensus.


PROFESSIONAL MEMBERSHIPS

Deputy Director of Surgery, Executive Director of Thyroid and Hernia Surgery, Secretary of the Third Party Branch

Chairman of the Thyroid Branch of Tumor Minimally Invasive Therapy Professional Committee of the Chinese Anti-Cancer Association;

Deputy Chairman of the Interventional Medicine Expert Committee of the National Health Commission;

Chief of the Thyroid and Parathyroid Group of the Surgery Branch of the Guangdong Medical Association;

Chairman of the Thyroid Expert Committee of the Provincial Pharmaceutical Association;

Member of the Thyroid Cancer Committee of the Chinese Anti-Cancer Association;

Member of the Thyroid Disease Committee of the Chinese Research Hospital Association;

Deputy Chairman of the Thyroid Physician Branch of the Guangdong Medical Association;

Deputy Chairman of the Thyroid Physician Branch of the Guangdong Anti-Cancer Association;

Standing Committee member of the Surgeon Branch of the Guangdong Medical Association.


PUBLICATIONS

1、Jianhao Huang; Muye Song; Hongyan Shi; Ziyang Huang; Shujie Wang; Ying Yin; Yijie Huang; Jialin Du; Sanming Wang; Yongchen Liu; Zeyu Wu*. Predictive Factor of Large-Volume Central Lymph Node Metastasis in Clinical N0 Papillary Thyroid Carcinoma Patients Underwent Total Thyroidectomy. Front Oncol. 2021 May 19;11:574774. (IF=6.244)

2、Muye Song; Ziyang Huang; Shujie Wang; Jianhao Huang; Hongyan Shi; Yongchen Liu*; Yijie Huang; Ying Yin; Zeyu Wu*. Predictive factors of lateral lymph node metastasis in conventional papillary thyroid carcinoma. Gland Surgery, 2020 Sep, 9(4): 1000-1007.(IF=2.953)

3、Huang ZY,Song MY,Li JH, Yin Y, Du JL, Wu ZY*.Preoperative Serum Thyroglobulin is a Risk Factor of Skip Metastasis in Papillary Thyroid Carcinoma. Annals of Translational Medicine. 2020 Mar;8(6):389. (IF=3.932)

4、Zhenwei Zhong, Jiru Yuan, Xiaohang Chen, Zhengbo Chen, Jialin Du, Zhijian Chen, Jian Kuang, Shuzhen Cong, Jinghua Li, Zeyu Wu*. The clinicopathological features of papillary thyroid carcinoma patients with positive Hepatitis B surface antigen. Oncology Research and Treatment. 2020;43(1-2):27-33.(IF 2.825)

5、Yuan JR, Zhao G, Du JL, Chen XY, Lin XD, Chen ZB, Wu ZY*. To identify predictors of central lymph node metastasis in patients with clinically node-negative conventional papillary thyroid carcinoma. International Journal of Endocrinology. 2016;2016:6109218. (IF=3.257)